[1] 刘京宇,周谋望,杨延砚,等.综合医院康复医学科脊髓损伤住院患者情况分析[J].中国康复医学杂志,2022,37(10):1360-1363.
[2] Anjum A, Yazid M D, Fauzi Daud M,et al.Spinal cord injury: pathophysiology, multimolecular interactions, and underlying recovery mechanisms[J]. Int J Mol Sci,2020,21(20):7533.
[3] Li C,Wu Z,Zhou L,et al. Temporal and spatial cellular and molecular pathological alterations with single-cell resolution in the adult spinal cord after injury[J]. Signal Transduct Target Ther,2022,7(1):65.
[4] Eli I, Lerner D P, Ghogawala Z. Acute traumatic spinal cord injury[J]. Neurol Clin,2021,39(2):471-488.
[5] Fan B, Wei Z, Yao X, et al.Microenvironment imbalance of spinal cord injury[J]. Cell Transplant,2018,27(6):853-866.
[6] 华晓琼,李彦杰,张淑芹,等.中医药调控脊髓损伤后肢体痉挛状态的机制及研究进展[J].中国老年学杂志,2023,43(7):1779-1782.
[7] Nagappan P G, Chen H, Wang D Y. Neuroregeneration and plasticity: a review of the physiological mechanisms for achieving functional recovery postinjury[J]. Mil Med Res,2020,7(1):30.
[8] Baltrusch S. The role of neurotropic B vitamins in nerve regeneration[J]. Biomed Res Int,2021,2021:9968228.
[9] Willand M P, Nguyen M A, Borschel G H, et al.Electrical stimulation to promote peripheral nerve regeneration[J]. Neurorehabil Neural Repair,2016,30(5):490.
[10] Faroni A, Mobasseri S A, Kingham P J, et al.Peripheral nerve regeneration: experimental strategies and future perspectives[J]. Adv Drug Deliv Rev,2015,82-83:160.
[11] 黄金生,张葛毅,李森瑞,等.淋巴管内皮细胞来源外泌体促进周围神经损伤后的轴突再生[J].中国组织工程研究,2023,27(33):5314-5319.
[12] Liu X, Zhang Y, Wang Y, et al.Inflammatory Response to Spinal Cord Injury and Its Treatment[J]. World Neurosurg,2021,155:19-31.
[13] 刘书画,李 艺,胡小莉,等.胶质细胞源性神经营养因子在脊髓损伤中的相关作用研究[J].赣南医学院学报,2021,41(09):965-970.
[14] 郭 栋,杨于冰,贺西京,等.生物支架联合嗅鞘细胞移植治疗脊髓损伤的研究进展[J].山西医科大学学报,2022,53(7):904-910.
[15] Rafieva L M, Gasanov E V. Neurotrophin propeptides: biological functions and molecular mechanisms[J]. Curr Protein Pept Sci,2016,17(4):298-305.
[16] Südhof T C. The cell biology of synapse formation[J]. J Cell Biol,2021,220(7):e202103052.
[17] Yamashita N, Kuruvilla R. Neurotrophin signaling endosomes: biogenesis, regulation, and functions[J]. Curr Opin Neurobiol,2016,39:139-45.
[18] 冯丹丹,黄维莉.活化T细胞及相关细胞因子在结直肠癌中的研究进展[J].吉林医药学院学报,2023,44(1):34-37.
[19] Shanley K L, Hu C L, Bizzozero O A. Proteasome composition in cytokine-treated neurons and astrocytes is determined mainly by subunit displacement[J]. Neurochem Res,2020,45(4):860-871.
[20] Dailey T, Tajiri N, Kaneko Y. Regeneration of neuronal cells following cerebral injury[J]. Front Neurol Neurosci, 2013,32:54-61.
[21] Kichula E A, Proud C M, Farrar M A,et al. Expert recommendations and clinical considerations in the use of onasemnogene abeparvovec gene therapy for spinal muscular atrophy[J]. Muscle Nerve,2021,64(4):413-427.
[22] Britten-Jones A C, Jin R, Gocuk S A,et al. The safety and efficacy of gene therapy treatment for monogenic retinal and optic nerve diseases: a systematic review[J]. Genet Med,2022,24(3):521-534.
[23] 张改玲,陶秀艳,刘兆丽,等.为过继性免疫治疗培养淋巴细胞时的细胞因子作用和基因表达特征[J].中国实验血液学杂志,2011,19(1):184-188.
[24] Jiang L, Jones S, Jia X. Stem cell transplantation for peripheral nerve regeneration: current options and opportunities[J]. Int J Mol Sci,2017,18(1):94.
[25] Assinck P, Duncan G J, Hilton B J,et al. Cell transplantation therapy for spinal cord injury[J]. Nat Neurosci,2017,20(5):637-647.
[26] 金元植,戎 鑫,刘 浩.外伤性脊髓损伤不同时期行干细胞移植治疗的研究进展[J].中国修复重建外科杂志,2013,4(19):1-6.
[27] Curtis E, Martin J R, Gabel B,et al. A First-in-Human, phase I study of neural stem cell transplantation for chronic spinal cord injury[J]. Cell Stem Cell, 2018,22(6):941-950.
[28] Huang L, Zhang L. Neural stem cell therapies and hypoxic-ischemic brain injury[J]. Prog Neurobiol,2019,173:1-17.
[29] O’Brien A L, West J M, Saffari T M,et al. Promoting nerve regeneration: electrical stimulation, gene therapy, and beyond[J]. Physiology (Bethesda),2022,37(6):10.
[30] Gordon T. Peripheral nerve regeneration and muscle reinnervation[J]. Int J Mol Sci, 2020,21(22):8652.
[31] Chen Y C, Ma N X, Pei Z F,et al. A neuroD1 AAV-Based gene therapy for functional brain repair after ischemic injury through in vivo astrocyte-to-neuron conversion[J]. Mol Ther,2020,28(1):217-234.
[32] Busuttil F, Rahim A A, Phillips J B. Combining gene and stem cell therapy for peripheral nerve tissue engineering[J]. Stem Cells Dev, 2017,26(4):231-238.
[33] De Winter F, Hoyng S, Tannemaat M,et al. Gene therapy approaches to enhance regeneration of the injured peripheral nerve[J]. Eur J Pharmacol,2013,719(1-3):145-152.
[34] Zhou Q, Zhang Y, Zou Y,et al. Human embryo gene editing: God's scalpel or Pandora’s box[J]. Brief Funct Genomics, 2020,19(3):154-163.
[35] Sudhakar V, Richardson R M. Gene therapy for neurodegenerative diseases[J]. Neurotherapeutics, 2019,16(1):166-175.
[36] 秦雅鑫,汤武装,施俊峰,等.脉冲电磁场对患者周围神经损伤后再生中的作用[J].脑与神经疾病杂志,2017,25(9):551-553.
[37] Lee J H,Kim K H,Kwon O H,et al. Photodynamic ctivity of rotoporphyrin ix-immobilized cellulose monolith for nerve tissue regeneration[J]. Int J Mol Sci,2022,23(3):1035.
[38] Jing X,Xu C,Su W,et al. Photosensitive and conductive hydrogel induced innerved bone regeneration for infected bone defect repair[J]. Adv Healthc Mater,2023,12(3):e2201349.